CLC bio

Source: Wikipedia, the free encyclopedia.
CLC bio
Company typePrivately held company
IndustryBioinformatics
Founded2005
Headquarters,
Area served
Denmark
Cambridge, Massachusetts
Tokyo
Taipei
Delhi
ProductsSoftware and consulting
Websitehttp://www.clcbio.com (dead)

CLC bio was a bioinformatics software company that developed a software suite subsequently purchased by QIAGEN.

History

CLC bio started commercial activities on January 1, 2005 headquartered in Aarhus, Denmark. Its product's development was also partly funded by collaborating with researchers on grant-funded projects.[1][2] By 2012, it had additional offices in Cambridge, Massachusetts, Tokyo, Taipei and Delhi, with staff largely from research backgrounds (30% having a PhD)[3] and had built a userbase of around 250,000 users in both academic institutions and biotechnology companies.[4][5]

CLC bio was acquired by QIAGEN in 2013 and merged into its bioinformatics research and development division with several other purchased platforms in 2014.[6][7][8]

Software

CLC bio's main activities were in software development for desktop (

REST API, and later, the ability to run containerized tools.[9]

As additional capabilities were added to the software platform, it was eventually split into several themed Workbenches and plugins with collections of features relevant to different applications (e.g.

data.

Cloud Computing

In 2017, CLC bio launched their CLC Genomics Cloud Engine[7] as a command-line driven platform for cloud-based bioinformatics workflow execution on Amazon Web Services. In 2019, this platform was adapted for and approved for use in AWS GovCloud. In 2020, CLC bio released a free plug-in that enables workflow execution on AWS directly from the CLC Genomics Workbench desktop software.[citation needed]

Hardware

Early on, the company initially presented own-developed

FPGA
technology. However these products are no longer under development.

References

  1. ^ "CLC Bio to Participate in $15M EU Effort to Study Stem Cell Differentiation Mechanisms". GenomeWeb. 2012-02-17. Retrieved 2022-11-29.
  2. ^ "EU Funds Development of Gene Regulation Software Suite". GenomeWeb. 2011-01-13. Retrieved 2022-11-29.
  3. ^ "Company profile (PDF)" (PDF). Archived from the original (PDF) on 2012-05-04. Retrieved 2012-05-29.
  4. ^ "Number of downloads". clcbio.com. 2012-02-05. Archived from the original on 2012-02-05.
  5. ^ "Customers". clcbio.com. 2012-10-05. Archived from the original on 2012-10-05.
  6. ^ "Bioinformatics Tools and Applications". QIAGEN Digital Insights. Retrieved 2022-11-29.
  7. ^ a b "Latest Improvements". QIAGEN Digital Insights. Retrieved 2022-11-30.
  8. ^ "About Us". QIAGEN Digital Insights. Retrieved 2022-11-30.
  9. ^ "Latest Improvements". Bioinformatics Software and Services: QIAGEN Digital Insights. Retrieved 2020-05-07.